1 / 28

… oh the failure

… oh the failure. Imogen Ketchley Sam Andrews. History. 54 yr old Male Retired engineer 1999 – Decompensated Alcoholic Liver Disease 2000 – Oesophageal Varices Banded. Presenting Complaint. Jaundice Abdominal Swelling Malaise. History of presenting complaint.

orla-greene
Download Presentation

… oh the failure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. … oh the failure Imogen Ketchley Sam Andrews

  2. History • 54 yr old • Male • Retired engineer • 1999 – Decompensated Alcoholic Liver Disease • 2000 – Oesophageal Varices Banded

  3. Presenting Complaint • Jaundice • Abdominal Swelling • Malaise

  4. History of presenting complaint • 3/52 – gradual onset and worsening of presenting symptoms • 1/52 – decreased urine output • 1/52 – hyperpigmentation of urine • 4/7 diarrhoea (no blood, no mucus) • Stools soft and dark (on iron) • No Haemetemesis

  5. Drug History • Frusemide – 40mg od • Spironolactone – 50mg od • FeSO4 – 200mg bd • Salbutamol – PRN • Multivitamins - bd

  6. Family/Social History • FH: • No liver disease, malignancies or other significant conditions. • SH: • Lives with wife in Colliers Wood • Work: Chauffeur (previously an engineer) • Smoker: 40 pack yrs • Alcohol: “gave up drinking three years ago” • Previously 48 units/wk

  7. On examination • CVS: • BP: 148/79 Pulse: 103 (regular) • Sats: 95% (on air) • HS: I + II + 0 • Bilateral Pitting Oedema of ankles and lower calf • Resp: • Fine creps on left and right bases

  8. Examination cont. • Abdo: • Spider Naevi • Jaundiced • Gross ascites • Enlarged firm liver edge • No splenomegaly • Abdomen soft and non-tender • Bowel sounds present • Extensive caput medusa • Gynaecomastia present • Neuro: • Grade 1 encephalopathy

  9. Blood Results - April 2003 • Hb: 11.5 (13 - 18 g/dL) • WBC: 6.1 (3.8 - 11x109/L) • Platelets: 83 (150 - 450x109/L) • MCV: 99.1 (78 - 96 FL)

  10. U’s & E’s and LFT’s - April 2003 • Na: 137 (135 - 145 mmol/L) • K: 3.9 (3.5 - 4.7 mmol/L) • Urea: 3.3 (2.5 - 8.0 mmol/L) • Creatinine: 67 (60 -110 µmol/L) • Bilirubin: 46 (0-17 µmol/L) • Alanine Transaminase: 49 (5 - 40 IU/L) • Albumin: 30 (38-48 g/L) • Gamma GT: 227 (0-60 IU/L)

  11. Blood Results on Presentation 7/10/03 • Hb – 12.3 (13-18 g/dL) • WBC – 16.6 (3.8-11x109/L) • Platelets – 77 (150-450x109/L) • MCV – 106 (78-96 FL)

  12. U’s & E’s and LFT’s7/10/03 • Na – 126 (135-145 mmol/L) • K – 3.8 (3.5-4.7 mmol/L) • Urea – 15.2 (2.5-8.0 mmol/L) • Creatinine – 369 (60-110 µmol/L) • Bilirubin – 576 (0-17 µmol/L) • Alanine Transaminase – 92 (5-40 IU/L) • Albumin – 21 (38-48 g/L) • Gamma GT – 167 (0-60 IU/L)

  13. Abdominal Ultrasound • Liver Cirrhosis • Ascites • Reversal of Portal Vein flow • Normal kidney’s

  14. In Summary • 54 year old Male • 4 year history of Alcoholic Liver Disease • Main Problems: • Jaundice due to cirrhosis • Ascites due to decompensated liver disease • Poor renal function

  15. Complications of Cirrhosis • Ascites develops late in the course; • Severe portal hypertension • Hepatic insufficiency • Poor survival: 50% mortality in 3 years • Clear indication for liver transplantation • Systemic Haemodynamics + Renal Function: • Better predictors of survival • Severe dysfunction in latest phases • Extremely poor prognosis.

  16. Pathogenesis • Complex interaction between: • portal hypertension • circulatory dysfunction • endogenous vasoactive systems • renal dysfunction • Backward Theory of Ascites Formation • Overflow Theory of Ascites Formation • The Peripheral Vasodilatation Hypothesis • The Forward Theory of Ascites Formation

  17. Peripheral Arterial Vasodilatation Hypothesis

  18. Hepatorenal Syndrome • Occurs in the final phase of the cirrhosis. • Defined as: • ‘The development of renal failure in patients with severe liver disease in the absence of any other identifiable cause of renal pathology’ • Prevelance: • 4% of patients admitted with decompensated cirrhosis.

  19. Differential Causes of Renal Failure • Diuretics • Ongoing Bacterial Infection • Spontaneous Bacterial Peritonitis • Nephrotoxic medications: • Aminoglycosides, NSAIDS, ACE inhibitors, platinum derivatives • Circulatory compromise • Variceal haemorrhage • Rapidly progressing glomerulonephritis

  20. Diagnostic Criteria • Chronic/acute liver disease with adv hepatic failure and portal hypertension • Creatinine  1.5 mg/dL • or • 24hr Creatinine Clearance < 40 mL/min • No alternative renal pathology • No improvement after diuretic withdrawal and expansion of plasma volume with 1.5 L of isotonic saline • Proteinuria < 500mg/d and no ultrasonographic evidence of obstructive uropathy or parencymal renal disease. • Urine Vol < 500 ml/day • Urine Na+ < 10mEq/L • Urine osmolality greater than plasma osmolality

  21. Evolution of Renal Dysfunction • Impaired renal sodium metabolism in compensated cirrhosis • Sodium retention without activation of the RAAS or sympathetic NS • Stimulation of the endogenous vasoconstrictor systems with preserved renal perfusion and GFR • Development of Type-2 HRS • Development of Type-1 HRS

  22. Treatment and Management • Bed Rest and Low Sodium Diet • Paracentesis and Fluid Management • Pharmacological Treatment • Terlipressin - Vasopressin Analogue • Parvolex - N-Acetylcysteine • Pentoxyphillin - Peripheral Vasodilator • Ursodeoxycholic acid - Treat 1o biliary cirrhosis • Sando - K - Treat potassium depletion • Multi-vitamins

  23. Progress • Improvement in liver function • Improvement in renal function • Although on going electrolyte disturbance • No unwanted effects observed

  24. Creatinine Clearance

  25. Further Management • The only effective and permanent treatment for HRS is orthotopic liver transplantation • Prognosis: • One year survival rate: 71% • Five year survival rate: 60%

More Related